Payam Baziyar
Overview
Explore the profile of Payam Baziyar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hosseini Faradonbeh S, Seyedalipour B, Keivan Behjou N, Rezaei K, Baziyar P, Hosseinkhani S
Front Mol Biosci
. 2025 Mar;
12:1532375.
PMID: 40070688
Protein stability is a crucial characteristic that influences both protein activity and structure and plays a significant role in several diseases. Cu/Zn superoxide dismutase 1 (SOD1) mutations serve as a...
2.
Seyedi Asl F, Malverdi N, Mojahedian F, Baziyar P, Nabi-Afjadi M
Int J Biol Macromol
. 2025 Feb;
306(Pt 1):141273.
PMID: 39978523
Alzheimer's disease (AD) is mostly thought to be caused by overactivity of glycogen synthase kinase 3-beta (GSK3-β). Therefore, a GSK-3β inhibitor may be a suggested medicine for Alzheimer's therapy. Nowadays,...
3.
Farrokhzad R, Seyedalipour B, Baziyar P, Hosseinkhani S
Proteins
. 2024 Dec;
93(4):885-907.
PMID: 39643934
Disturbances in metal ion homeostasis associated with amyotrophic lateral sclerosis (ALS) have been described for several years, but the exact mechanism of involvement is not well understood. To elucidate the...
4.
Ashkaran F, Seyedalipour B, Baziyar P, Hosseinkhani S
BMC Chem
. 2024 Sep;
18(1):177.
PMID: 39300574
Despite the many mechanisms it has created to prevent unfolding and aggregation of proteins, many diseases are caused by abnormal folding of proteins, which are called misfolding diseases. During this...
5.
Baziyar P, Seyedalipour B, Hosseinkhani S, Nazifi E
Iran J Biotechnol
. 2024 Feb;
20(4):e3178.
PMID: 38344317
Background: One neurodegenerative disorder that is caused by a mutation in the hSOD1 gene is Amyotrophic lateral sclerosis (ALS). Objectives: The current study was developed in order to evaluate the...
6.
Noorbakhsh Varnosfaderani S, Haeri M, Arian A, Yousefi Rad A, Yazdanpour M, Mojahedian F, et al.
J Biomol Struct Dyn
. 2023 Nov;
43(1):419-436.
PMID: 37975411
Protein aggregation is a biological process that occurs when proteins misfold. Misfolding and aggregation of human superoxide dismutase (hSOD1) cause a neurodegenerative disease called amyotrophic lateral sclerosis (ALS). Among the...
7.
Qassim H, Seyedalipour B, Baziyar P, Ahamady-Asbchin S
Comput Biol Chem
. 2023 Oct;
107:107967.
PMID: 37844376
Aggregation of proteins is a biological phenomenon caused by misfolded proteins. Human superoxide dismutase (hSOD1) misfolding and aggregation underlie the neurological illness amyotrophic lateral sclerosis (ALS). The most significant contributing...
8.
Sharbatdar Y, Mousavian R, Noorbakhsh Varnosfaderani S, Aziziyan F, Liaghat M, Baziyar P, et al.
Inflammopharmacology
. 2023 Apr;
31(3):1029-1052.
PMID: 37079169
According to recent researches, people with diabetes mellitus (type 1 and 2) have a higher incidence of coronavirus disease 2019 (COVID-19), which is caused by a SARS-CoV-2 infection. In this...
9.
Ebrahimi N, Pazhouhesh Far N, Fakhr S, Faghihkhorasani F, Miraghel S, Chaleshtori S, et al.
Environ Res
. 2023 Apr;
228:115914.
PMID: 37062475
Despite numerous prevention methodologies and treatment options, hepatocellular carcinoma (HCC) still remains as the third leading life-threatening cancer. It is thus pertinent to develop new treatment modality to fight this...
10.
Ebrahimi N, Fardi E, Ghaderi H, Palizdar S, Khorram R, Vafadar R, et al.
Cell Mol Life Sci
. 2023 Mar;
80(4):104.
PMID: 36947256
Targeted therapy is a new cancer treatment approach, involving drugs that particularly target specific proteins in cancer cells, such as receptor tyrosine kinases (RTKs) which are involved in promoting growth...